BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/15/2025 8:26:21 AM | Browse: 39 | Download: 237
 |
Received |
|
2025-04-15 09:20 |
|
Peer-Review Started |
|
2025-04-16 08:38 |
|
First Decision by Editorial Office Director |
|
2025-04-24 02:51 |
|
Return for Revision |
|
2025-04-24 02:51 |
|
Revised |
|
2025-04-26 12:48 |
|
Publication Fee Transferred |
|
2025-04-30 11:00 |
|
Second Decision by Editor |
|
2025-05-22 01:00 |
|
Second Decision by Editor-in-Chief |
|
2025-05-22 08:25 |
|
Final Decision by Editorial Office Director |
|
2025-05-29 08:24 |
|
Articles in Press |
|
2025-05-29 08:24 |
 |
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-03 00:38 |
|
Publish the Manuscript Online |
|
2025-07-15 08:26 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of microRNA-495-3p, adiponectin, and cardiometabolic index in type 2 diabetic nephropathy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xu-Chun Xu, He-Jing Fang and Hua-Ying Huang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xu-Chun Xu, MD, Department of Nephrology, Jinhua Municipal Central Hospital, No. 365 Renmin East Road, Jinhua 321000, Zhejiang Province, China. xuchunxu099@163.com |
| Key Words |
Diabetes mellitus; Type 2 diabetic nephropathy; Cardiometabolic index; Adiponectin; Serum miR-495-3p |
| Core Tip |
This study identifies serum microRNA-495-3p (miR-495-3p), adiponectin (ADPN), and cardiometabolic index (CMI) as novel biomarkers for predicting poor prognosis in type 2 diabetic nephropathy (T2DN). Lower miR-495-3p and higher ADPN/CMI levels correlate with worse renal outcomes, offering clinical utility for risk stratification. Multivariate analysis confirms their independent predictive value alongside liver/kidney function markers. These findings highlight miR-495-3p’s potential as a key prognostic indicator, advancing personalized management strategies for T2DN. |
| Publish Date |
2025-07-15 08:26 |
| Citation |
Xu XC, Fang HJ, Huang HY. Prognostic value of microRNA-495-3p, adiponectin, and cardiometabolic index in type 2 diabetic nephropathy. World J Diabetes 2025; 16(7): 108262 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i7/108262.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i7.108262 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
